ByHeart's Whole Nutrition Infant Formula is the first Clean Label Project certified infant formula in the United States and it has been recognized at the highest tier with "The Purity Award." Fueled by a patented blend of the two most abundant proteins in breast milk as well as organic, grass-fed whole milk, the farm-to-formula product is backed by clinical trial results that boast benefits that rival breast milk. Unlike formulas that rely on skim milk, this one delivers benefits with organic, grass-fed whole milk and without corn syrup, maltodextrin, soy, or palm oil.
Notably, ByHeart is the first new infant formula manufacturer in over 15 years to be registered with FDA, which makes it only the fourth vertically integrated infant formula brand in the United States.
Whole Nutrition Infant Formulas
ByHeart's Formula Proves Next-to-Breast Milk Benefits
Trend Themes
1. Clean Label Infant Formulas - Clean Label Project certification can disrupt the infant formula market by increasing demand for organic, grass-fed, and whole milk-based formulas.
2. Patented Breast Milk Protein Blend - The patented blend of the two most abundant proteins in breast milk can create new opportunities for infant formula manufacturers to develop formula that can provide similar benefits to breast milk.
3. Vertically Integrated Formula Manufacturers - The emergence of ByHeart as a vertically integrated infant formula brand could disrupt long-established infant formula brands and benefit consumers by providing a direct supply chain and potentially lowering prices.
Industry Implications
1. Infant Formula Market - The Clean Label Project certification and ByHeart's entrance to the market could disrupt the long-established infant formula market and create opportunities for organic, whole food-based formula brands.
2. Dairy Industry - The demand for organic, grass-fed, and whole milk-based formula could positively impact the dairy industry and open up new distribution channels for small-scale milk producers.
3. Clinical Trials Industry - The use of clinical trials to validate the efficacy of infant formula could become more prevalent and standardized as new formulas emerge that are more similar to breast milk.